Preshaw P M, Geatch D R, Lauffart B, Jeffcoat M K, Taylor J J, Heasman P A
Ohio State University, Columbus, USA.
J Clin Periodontol. 1998 Oct;25(10):774-80. doi: 10.1111/j.1600-051x.1998.tb02369.x.
The aim of this study was to gain information of the cellular and molecular events which occur during the development of experimental gingivitis and to determine whether such changes occur in the presence or absence of alveolar bone resorption. Clinical, radiographic, biochemical and immunological variables were monitored in a 3-week, single-centre, experimental gingivitis study of 10 healthy volunteers. Following screening and professional prophylaxis to achieve visibly healthy gingival status, subjects abstained from all oral hygiene practises in one maxillary (test) quadrant for a period of 21 days. At days 0 and 21, in test and (contralateral) control quadrants, % bleeding on controlled pressure probing (% BOP) was calculated, and radiographic alveolar bone status was assessed using bilateral standardised vertical bite-wing radiographs and digital subtraction radiography (DSR) analysis. In test quadrants, gingival crevicular fluid (GCF) was sampled from 4 sites per subject with Periopaper strips, and prostaglandin E2 (PGE2) levels measured using an enzyme immunoassay (EIA) kit. At days 0, 7 and 21, one interdental papilla was surgically excised from the test quadrant, and the expression of T cell receptor B variable (TCRBV) genes was investigated using a reverse transcription-polymerase chain reaction (RT-PCR) procedure. At days 0, 7 and 21, peripheral blood lymphocytes (PBL) were isolated and additionally investigated for TCRBV gene expression. Following 21 days of plaque accumulation in test quadrants, a statistically significant increase in % BOP scores confirmed the presence of gingival inflammation (p<0.001). DSR analysis revealed that there were no significant alveolar bone changes in either the test or control quadrants between days 0 and 21 (p>0.05). EIA analysis of GCF samples identified a significant decrease in mean GCF PGE2 concentrations from day 0 to day 21 (p<0.05). RT-PCR analysis indicated that genes from all 3 TCRBV families studied (TCRBV-2, -6, -8) were expressed in the PBL samples at all time points and in healthy gingival tissues at day 0. A restriction in the expression pattern of TCRBV genes similar to those which have previously been reported in chronic periodontitis was noted at gingivitis sites. It is possible that such an event may identify susceptibility to periodontal disease independently of other positive predictive markers such as GCF-PGE2.
本研究的目的是获取实验性牙龈炎发展过程中发生的细胞和分子事件的信息,并确定这些变化是否在存在或不存在牙槽骨吸收的情况下发生。在一项针对10名健康志愿者的为期3周的单中心实验性牙龈炎研究中,对临床、影像学、生化和免疫学变量进行了监测。在进行筛查和专业预防以达到明显健康的牙龈状态后,受试者在上颌一个象限(测试象限)内停止所有口腔卫生措施,为期21天。在第0天和第21天,在测试象限和(对侧)对照象限计算控制压力探诊时的出血百分比(%BOP),并使用双侧标准化垂直咬翼片和数字减影放射摄影(DSR)分析评估影像学牙槽骨状态。在测试象限,使用Periopaper纸条从每个受试者的4个部位采集龈沟液(GCF),并使用酶免疫测定(EIA)试剂盒测量前列腺素E2(PGE2)水平。在第0天、第7天和第21天,从测试象限手术切除一个龈乳头,并使用逆转录-聚合酶链反应(RT-PCR)程序研究T细胞受体B可变区(TCRBV)基因的表达。在第0天、第7天和第21天,分离外周血淋巴细胞(PBL),并额外研究TCRBV基因表达。在测试象限菌斑堆积21天后,%BOP评分的统计学显著增加证实了牙龈炎症的存在(p<0.001)。DSR分析显示,在第0天至第21天期间,测试象限或对照象限均未出现明显的牙槽骨变化(p>0.05)。对GCF样本的EIA分析表明,从第0天到第21天,平均GCF PGE2浓度显著降低(p<0.05)。RT-PCR分析表明,所研究的所有3个TCRBV家族的基因(TCRBV-2、-6、-8)在所有时间点的PBL样本中以及在第0天的健康牙龈组织中均有表达。在牙龈炎部位发现了与先前在慢性牙周炎中报道的类似的TCRBV基因表达模式的限制。这种事件有可能独立于其他阳性预测标志物(如GCF-PGE2)来识别对牙周病的易感性。